Mark C. Schneyer, EVP, CHIEF FINANCIAL OFFICER at ACADIA PHARMACEUTICALS INC (ACAD), sold 772 shares at $24.67 ($19K) on 2024-02-26, disclosed to the SEC on 2024-02-27.
Scheduled sale ($19k) by EVP, CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ACAD | SELL | 2026-04-07 | $60K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $160K | — | Filing → |
| ACAD | SELL | 2025-11-19 | $486K | — | Filing → |